Omada Health, Inc.: director Julie D Klapstein received 549 shares

What happened Julie D Klapstein, director, received a grant of 549 restricted stock units (RSUs) on Oct 5, 2026. The Form 4 reports a grant price of $0.00 and an aggregate acquisition amount of $0.00.

Key details

• Transaction date: Oct 5, 2026. Filing date: Oct 7, 2026 (filed 2 days after the transaction).
• Transaction code: A (award/grant).
• Amount: 549 RSUs; price per share: $0.00; total reported value: $0.00.
• Shares owned after the transaction: not reported in the filing.
• Footnote F1: RSUs were granted under the issuer's Non-Employee Director Compensation Program in lieu of retainer fees. Each RSU represents the right to receive one share of common stock, with settlement either on a date selected by the reporting person or as otherwise provided by the Program.
• Filing timeliness: filing date is Oct 7, 2026; the Form 4 does not indicate that the filing was late.

Why it may matter

• This was an award/grant of RSUs (not a market purchase or sale); settlement into shares may occur later per the program terms.
• A filing does not show why the insider traded or why the company acted.